The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Cetuximab-related skin toxicity in metastatic colorectal cancer (mCRC) patients and its correlation with molecular markers: Results from the German AIO CRC 0104 trial.
Sebastian Stintzing
Honoraria - Merck Serono
Research Funding - Merck Serono
Christine Kapaun
No relevant relationships to disclose
Ruediger P. Laubender
No relevant relationships to disclose
Andreas Jung
Honoraria - Merck Serono
Jens Neumann
No relevant relationships to disclose
Dominik Paul Modest
No relevant relationships to disclose
Clemens Albrecht Giessen
No relevant relationships to disclose
Nicolas Moosmann
No relevant relationships to disclose
Andreas Wollenberg
Research Funding - Merck Serono
Thomas Kirchner
Honoraria - Merck Serono; Roche
Research Funding - Merck Serono; Roche
Expert Testimony - Merck Serono; Roche
Volker Heinemann
Honoraria - Merck Serono; Roche
Research Funding - Merck Serono; Pfizer; Roche; Sanofi
Expert Testimony - Merck Serono